• Torin 1: Advanced mTOR Inhibitor for Precision Pathway Re...

  2025-10-22

  Torin 1 stands apart as an ATP-competitive mTOR inhibitor, unlocking precise control of mTORC1 and mTORC2 signaling for advanced cancer and lipid metabolism studies. Its dual-complex inhibition and superior efficacy over rapamycin empower researchers to dissect rapamycin-resistant pathways, modulate autophagy, and probe cell cycle arrest with unmatched specificity.

• Imatinib (STI571): Mechanistic Precision and Translationa...

  2025-10-21

  This thought-leadership article explores the mechanistic foundations and translational impact of Imatinib (STI571), a selective protein-tyrosine kinase inhibitor. Designed for translational researchers and scientific leaders, the narrative integrates current evidence, competitive context, and practical guidance, while highlighting new frontiers in kinase signaling, tumor microenvironment research, and the evolving implications for cancer biology.

77 records 6/6 page Previous First page 上5页 6